To explore the function of RPL39 in glioma, siRPL39 and Flag-RPL39 plasmids were used to specifically knock down and overexpress RPL39, respectively, and western blotting was performed to assess the efficacy of the plasmids (Figure 11A). The gene discussed is RPL39; the disease is central nervous system cancer.